Tirzepatide treatment for obesity sees weight loss maintained up to 88 weeks

According to research published in JAMA, tirzepatide treatment for adults with obesity sees some success in maintaining weight loss. The study saw patients who received 36 weeks of treatment maintaining weight loss after treatment ended for 88 weeks, though continued treatment is necessary to maintain improvements.

Healio